Biomarker-guided antifungal therapy in patients with suspected invasive candidiasis: Ready for prime time?

about

Biomarker-guided antifungal therapy in patients with suspected invasive candidiasis: Ready for prime time?

Item

http://www.wikidata.org/entity/Q50101377

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Biomarker-guided antifungal th ...... idiasis: Ready for prime time?

@en

Biomarker-guided antifungal th ...... idiasis: Ready for prime time?

@nl

type

Item

label

Biomarker-guided antifungal th ...... idiasis: Ready for prime time?

@en

Biomarker-guided antifungal th ...... idiasis: Ready for prime time?

@nl

prefLabel

Biomarker-guided antifungal th ...... idiasis: Ready for prime time?

@en

Biomarker-guided antifungal th ...... idiasis: Ready for prime time?

@nl

P1476

Biomarker-guided antifungal th ...... idiasis: Ready for prime time?

@en

P2093

Pierre-Emmanuel Charles

http://www.w3.org/2001/XMLSchema#string

P2860

Executive Summary: Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America

Intensive care medicine research agenda on invasive fungal infection in critically ill patients.

Epidemiology and Risk Factors for Echinocandin Nonsusceptible Candida glabrata Bloodstream Infections: Data From a Large Multisite Population-Based Candidemia Surveillance Program, 2008-2014

Characteristics and risk factors for 28-day mortality of hospital acquired fungemias in ICUs: data from the EUROBACT study

Serum procalcitonin for the early recognition of nosocomial infection in the critically ill patients: a preliminary report

Antifungal de-escalation was not associated with adverse outcome in critically ill patients treated for invasive candidiasis: post hoc analyses of the AmarCAND2 study data.

Posttreatment Antifungal Resistance among Colonizing Candida Isolates in Candidemia Patients: Results from a Systematic Multicenter Study.

Systemic antifungal therapy for proven or suspected invasive candidiasis: the AmarCAND 2 study.

Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016.

Efficacy and safety of procalcitonin guidance in reducing the duration of antibiotic treatment in critically ill patients: a randomised, controlled, open-label trial.

P2888

s00134-017-4990-y

P304

1889-1891

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

editorial

P356

10.1007/S00134-017-4990-Y

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

JA Paiva

P577

2017-11-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29119220

http://www.w3.org/2001/XMLSchema#string